LalanaChami Pharmacy Management System Registration /api/user/signup role access control
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.4 | $0-$5k | 0.00 |
Summary
A vulnerability marked as critical has been reported in LalanaChami Pharmacy Management System. This vulnerability affects unknown code of the file /api/user/signup of the component Registration Handler. The manipulation of the argument role leads to access control. This vulnerability is uniquely identified as CVE-2026-31070. The attack is possible to be carried out remotely. No exploit exists.
Details
A vulnerability was found in LalanaChami Pharmacy Management System (the affected version is unknown). It has been rated as critical. This issue affects an unknown code of the file /api/user/signup of the component Registration Handler. The manipulation of the argument role with an unknown input leads to a access control vulnerability. Using CWE to declare the problem leads to CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
The LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to escalate privileges by self-assigning an administrative role during registration. The /api/user/signup endpoint fails to validate the role parameter in the request body
The advisory is shared at github.com. The identification of this vulnerability is CVE-2026-31070 since 03/09/2026. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. Technical details are known, but no exploit is available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 05/23/2026). MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.5VulDB Meta Temp Score: 8.4
VulDB Base Score: 7.3
VulDB Temp Score: 7.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
ADP CISA Base Score: 9.8
ADP CISA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Access controlCWE: CWE-284 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
03/09/2026 CVE reserved05/19/2026 Advisory disclosed
05/19/2026 VulDB entry created
05/23/2026 VulDB entry last update
Sources
Advisory: github.comStatus: Not defined
CVE: CVE-2026-31070 (🔒)
GCVE (CVE): GCVE-0-2026-31070
GCVE (VulDB): GCVE-100-364697
Entry
Created: 05/19/2026 22:31Updated: 05/23/2026 14:37
Changes: 05/19/2026 22:31 (54), 05/23/2026 14:37 (11)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.